Plasma Transport Proteins in Patients with Tuberculosis and COVID-19 at the Stages of Treatment

The objective : to assess changes in the level of lactoferrin and ferritin patients with pulmonary tuberculosis COVID-19 during treatment, determine their correlation parameters free radical oxidation antioxidant protection. Subjects methods . Levels erythrocyte catalase ferritin, neutrophil myeloperoxidase were studied against background successful treatment group (n = 80) 75). Their protection was assessed. Results. Before median increased both groups, but Group, it significantly more pronounced. At end intensive phase Tuberculosis Group when clinical improvement achieved decreased. Increased activity decreased also noted groups before start; higher versus which correlated a this group. After achievement COVID-19, there decrease levels myeloperoxidase, coincided ferritin. There direct strong between myeloperoxidase-ferritin (r 0.80; p < 0.01) myeloperoxidase-lactoferrin 0.73; 0.01). Against intracellular almost reaching normal value. Also, is inverse -0.79;